End on April 8, 39 medicine enterprise is announced 2020 outstanding achievement is premonitory first quarter, among them net profit is decreased slightly, head deficient, decrease beforehand have 16, 23 net profit is added slightly, add beforehand, twist deficient. Wait with medicine of mountain drug industry, Wo Hua among them get new hat influence of pneumonic epidemic situation, sale of anti-current feeling medicaments soars; Kang Enbei, An Shengtang suffer auxiliary extract an effect with market of medicine, nation, partial product sale drops considerably; 9 how to supply epidemic situation actively medical treatment, Pu Yang medical treatment relevant product, net profit turns over times.
Remarks: Fortune of data origin east
Epidemic situation issues disease-resistant bane content to sell greatly
Fluid of poisonous profess to convinced of Lian Huaqing acute communicable diseases, disease-resistant...
Outside spending clear Wen Hai repeatedly with mountain drug industry, explode red
Spend capsule of clear acute communicable diseases to be included during new coronal is pneumonic repeatedly with mountain drug industry " the plan of pneumonic diagnosis and treatment that virus of new-style coronal shape affects " in recommending officinal, occupy what announce with mountain drug industry 1 quarter outstanding achievement is premonitory 2020 show, predict profit of 1 quarter net profit 43, two million five hundred and fifty-one thousand six hundred yuan of ~46, one million three hundred and eighty-eight thousand four hundred yuan, grow 50%-60% compared to the same period.
In national Wei Jian appoint those who release " the plan of pneumonic diagnosis and treatment that virus of new-style coronal shape affects (try out the 5th edition) " in,
The near future, new coronal is pneumonic and abroad epidemic situation erupts, according to coverage of much home media, explode even market of overseas of capsule of the acute communicable diseases that spend Qing Dynasty red, domestic retail price ten yuan Lian Huaqing acute communicable diseases, already was fried nearly 100 in foreign price, and do not have supply of goods certainly. And also developing overseas market actively with near future of mountain drug industry, the near future spends capsule of clear acute communicable diseases to be obtained in Thailand repeatedly register batch of article.
End at present, outside dividing Thailand, already was in even capsule of the acute communicable diseases that spend Qing Dynasty Hong Kong area, Macao area and Brazil, Indonesia, Canada, Mozambique, Romania to part with " medium officinal " , " medicines and chemical reagents " , " plant medicine " , " natural and healthy product " , " food replenishers " wait for the identity to register obtain appear on the market.
This extends overseas market to bring positive effect to the company, from capital the reaction of the market also can see, end now closing quotation, below this epidemic situation bestow favor on newly already harden.
Profit of net of Wo Hua medicine turns over 2 times
Wo Hua medicine 1 quarter is clean 2020 profit thirty-six million five hundred and forty-four thousand eight hundred yuan of ~ 4466.58 10 thousand yuan, grow 170% ~ 230% compared to the same period.
1 quarterly outstanding achievement of company relatively go up year of main reason that the corresponding period grows considerably: Above all, during epidemic situation, the company produces the competitive advantage of the exclusive product that accumulates for years adequately, capture national medical service quickly to protect bureau keep drug about chronic cure " long prescription " policy good luck, the Wo Huaxin that drives remedial chronic with all one's strength but Shu Pian, bone is scanty health capsule / red of grain, carry on one's shoulder piece / fluid of scanty profess to convinced of blood of capsule, head the sale of product of 4 big exclusive mainstay, make sales revenue obtains rapidder growth first quarter.
Next, the company recommends medicaments Qing Dynasty to heat up detoxify in yield national epidemic situation at present kind medicines and chemical reagents basically connects pear syrup of holy bolus, tangerine, kite to catch a cold for the root of fangfeng fluid of poisonous profess to convinced of grain, disease-resistant, children is antifebrile Xi Ling of bolus of the rhizome of large-headed atractylodes of Ling of grain, ginseng, compound is alexipharmic piece, , the company been doinging the organization below defended premise to work overtime produce this kind of drug, for sales revenue contributed new point of growth first quarter.
Finally, the company continues to advance essence of life to refine management deep, accelerate during epidemic situation advance digitlization transition, use the sale method such as the promotion on the line extensively, quicken the resource below the line on integrated line, reduced sale cost significantly. Purchase, the digitlization transition of the respect such as production, finance affairs and manpower resource is synchronous also advance, promoted management efficiency.
Collect collects breed to the limit of one's capacity remarkable, battalion closes, net profit double glide
The auxiliary sale that use drug drops considerably
Collect of vast unripe hall adopts variety " favour for Ka Wei " sales volume increases 480% , battalion closes, net profit glides
An Shengtang 1 quarterly outstanding achievement is premonitory 2020 show, company battalion income predicts to drop compared to the same period 17.73%~26.87% , net profit predicts to drop compared to the same period 66.93% – 86.77% .
Above all, the company fights Gan Ding of A of medicaments of second liver virus - ester of A Defu Wei piece, favour Gan Ding - favour for Ka Wei capsule parts in September 2019, win the bid successfully in January 2020 national medicines and chemical reagents is purchased centrally. Among them, favour pleasant is purchased centrally surely already in December 2019 the portion begins to carry out. Inside report period, favour pleasant decides selling quantity to predict to grow 480% compared to the same period. In addition, suffer cure to protect accuse cost, concentration to purchase wait for policy impact, drug price falls somewhat, the company fights battalion of product of medicaments of second liver virus to close, net profit drops.
Inside report period, rich of Fujian of company affiliated company abstruse medicine examines a limited company make go back to work of the Fuzhou City from personnel of course of study virus of new-style coronal shape is appointed detect unit, detect business increases.
Monitoring of key of health favour shellfish uses drug " fluid of inject of Qin of the rhizome of chuanxiong of the root of red-rooted salvia " sale drops compared to the same period 83%
Kang Enbei 1 quarter outstanding achievement is premonitory 2020 show, predicting battalion receives 1.67 billion yuan, drop compared to the same period about 4% . Among them, fluid of inject of Qin of the rhizome of chuanxiong of the root of red-rooted salvia of core product card (compensate red) continue to suffer catalog of monitoring of key medicines and chemical reagents to come on stage to protect catalog to adjust with cure wait for policy to deepen influence and market environment effect continuously, sales revenue reduces about 355 million yuan compared to the same period, drop compared to the same period about 83% .
Deduct fluid of inject of Qin of the rhizome of chuanxiong of the root of red-rooted salvia after sales revenue, the company predicts 2020 do business first quarter income is 1.597 billion yuan, relatively grow about 22% with caliber first quarter 2019.
Product of great variety of main old brand is like the company " Jin Di " mixture of card compound cordate houttuynia, " Jin Aikang " element of armour of card Chinese the root of fangji, " Jin Kang fast force " acerbity bubble of half Guang ammonia vacates card acetyl piece, " Kang Enbei, and product of big healthy business if " cherish bright " product of series of card eye health, vitamin kind the sale such as health food grows good; but capsule of Jin Tonglin of dragon of breed of partial prescription drug, summer does not have series product to wait suffer terminal market environment to affect a sale to drop somewhat.
Company of medical apparatus and instruments is global related epidemic situation be benefited remarkable
Medical treatment serves kind suffer an effect bigger
Suffer epidemic situation effect, implementation of profit of net profit of company of partial medical apparatus and instruments turns over times, include apparatus of state of Baolaite, reason to wait, net profit all grows considerably.
1 quarter predicted Baolaite 2020 net profit 3, 872.33~4, one million nine hundred and fifty thousand three hundred yuan, grow 140%~160% compared to the same period. Because,basically be during epidemic situation, company blood purifies business to maintain normal evolution, and firm health is monitored kind (system of tutelar appearance, hematic oxygen appearance, wireless temperature) product sales revenue relatively grow substantially.
1 quarter predicted reason state medical treatment 2020 net profit 8, 099.54~8, 4.677 million yuan, increase compared to the same period 120% , 130% . Net profit grows considerably basically is epidemic situation during, in original produce the foundation of the line to go up to open many product line newly, main safeguard epidemic situation is relevant the supply of the product. Company epidemic situation is diagnosed outside relevant custody, body - growth of product line of phone of courage and uprightness, heart is rapid, the company grows quickly via battalion outstanding achievement first quarter.
Hospital outpatient service, content suffers to spread an effect during epidemic situation, partial company occurrence loss
1 quarter realized Wo Sensheng thing 2020 first deficit, predicting deficit 1, 800~2, 3 million yuan. Deficit reason is epidemic situation during, vaccinal admittance and administration and each province, city, county (area) center of control of class disease precaution throws the job that fight epidemic disease with all one's strength, outpatient service of majority vaccine have an inoculation is prevented because of new coronal epidemic situation control a demand and suspend vaccination; sufferring traffic content to spread effect halting use, vaccinal product deserves to send also encounter very great difficulty. Virus of new-style coronal shape affects situation of pneumonic epidemic situation to worsen continuously outside near future condition, company international marketing faces bigger challenge, like the epidemic situation outside the condition grim situation lasts, the company returns existence part entrance to produce Yuan Fucai makings to purchase the risk that bears an influence.
Industry of boreal land drug predicts 1 quarter profit 2, 433.96~3, six million five hundred and nine thousand four hundred yuan, drop compared to the same period 40% , 10% . Advocate if get new hat,pneumonic epidemic situation is affected, hospital of countrywide each district is active beat back epidemic situation, partial hospital still did not return to normal up to now outpatient service, outpatient service quantity, check measure quantity, operation to all drop the quantity considerably, demand of terminal of sale of medicines and chemical reagents is affected; apparently in addition, content shedding is carried be accused by certain level canal, also bring about company outstanding achievement relatively the corresponding period dropped somewhat last year.
Origin: Company announcement
